The patented device provides a cuff of and artificial urethral sphincter, which allows for the safe and reliable occlusion of the urethral duct. Specific accessory devices entail the inflation and deflation of the cuff with saline, leading to occlusion or disocclusion of the urethra. In this way the device makes it possible to control micturition in the case of subjects that are affected by urinary incontinence.
Nowadays, urinary incontinence is one of the principal healthcare problems worldwide and the associated socio-economic costs are enormous. The artificial urinary sphincter represents the gold standard treatment, with particular regard to male subjects. The commercially available devices are still affected by different limitations and major concerns: more than 50% of implanted devices fail. During urethra occlusion, current devices implicate non- uniform mechanical solicitation of biological tissues, leading to regions where excessive stress and strain ape applied.
Vasoconstriction phenomena and subsequent tissue inflammation occur, leading to stricture formation. Sometimes, the device determines urethra erosion.

TRL (Technology Readiness Level)

TRL 3 / 9

Inventors

Carniel Emanuele Luigi

Fontanella Chiara Giulia

Natali Arturo Nicola

Download the brochure

  • A Method for Allocation of Fenestrations in Patient-Specific Aortic Endografts

    Fenestrated aortic endografts are used to treat aneurysmal aortic pathologies. These devices feature fenestrations at the origin of the renal and visceral arteries to preserve their patency. Traditionally, manufacturers determine the precise location of these fenestrations through specific measurements and...

  • Method for the automatic tracking of the fascial system displacement in ultrasound videos for objective site-specific evaluation and personalized treatment planning and prevention

    The proposed algorithm has the capability to qualitatively and quantitatively evaluate the gliding between the multiple substrates of the fascial system as a biomarker for a variety of different clinical conditions (e.g. low back pain) before-during-after treatment and in follow-up....

  • Glioblastoma multiforme: a new prognostic index of survival

    Glioblastoma (GBM) is the most common brain cancer among adults and patients and has an overall survival (OS) of 15 months. Nowadays brain tumours are not taken in evaluation in relation to the brain area in which they are located....

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation